MPS Q1 FY27 Earnings Call — Analysis (NSE: MPSLTD)

MPS Q1 FY'27 revenue rose 20% YoY to ₹224 Cr, EBITDA surged 53% to ₹77 Cr with margin hitting 34.3%, and management reaffirmed FY'27 EBITDA comfortable crossing ₹300 Cr as a floor.

29 Jul 2026 · Analysis by Alpha Inflection

The take

Q1FY27 Revenue ₹224.24 Cr ( +20.4% YoY ) . New guidance — FY28 fy'28 revenue ₹1,500 Cr . New story: Outcomes-based revenue shift .

Results

Q1FY27 revenue ₹224.24 Cr +20.4% YoY; EBITDA ₹76.96 Cr +53.0% YoY; EBITDA margin 34.3% (+730 bps from 27.0%); PAT ₹50.39 Cr +43.0% YoY; EPS ₹29.70, an all-time Q1 high.

Financial highlights

Guidance

FY'27 EBITDA expected to comfortably cross ₹300 Cr, treated as a floor; FY'28 revenue target ~₹1,500 Cr, EBITDA ~₹450 Cr.

What management committed to

• MPS will comfortably cross INR 300 crores in EBITDA in FY'27. — cross INR 300 crores, FY27
• MPS targets approximately INR 1,500 crores in revenue for FY'28. — INR 1,500 crores, FY28
• MPS targets around INR 450 crores in EBITDA for FY'28. — INR 450 crores, FY28
• Corporate Learning segment will hold its Q1FY27 exit margin of approximately 25.3% as the run rate for the rest of FY'27. — 25.3%, FY27
• MPS is hopeful of clearing the Rule of 50 (revenue growth % + EBITDA margin % greater than 50) for the full FY'27. — Rule of 50, FY27
• MPS will not raise equity for acquisitions in the ₹300-500 Cr range; financing will be done through internal cash accruals and debt. — no equity, cash-plus-debt
• The accessibility line in [MPS Education] will complete a large journals rollout later this year (FY'27). — large journals rollout, FY27

Key themes

Outcomes-based revenue and margin expansion

How the narrative shifted

• Outcomes-based revenue shift: Management positions the shift from effort-based (pages, hours) to outcomes-based pricing (accepted manuscripts, trusted integrity decisions, subscription renewals) as the structural driver of margin expansion and competitive defensibility.
• AI embedded in delivery: AI is presented as fully operational across production, integrity, and quality workflows, generating tangible productivity and margin gains rather than remaining a slideware concept.
• Corporate Learning turnaround: Corporate Learning has been restructured (headcount reduced by a third, gig model, fixed-to-variable cost shift) and is now delivering margin recovery and profitable growth, positioning it as a contributor to overall margin expansion.
• Education pillar scaling with Unbound: Unbound Medicine adds a high-renewal, recurring subscription base that reduces customer concentration and predictability risk, while offering cross-sell synergies with Liberate; Education segment becomes a second growth engine.
• Conservative yet confident guidance: Management reaffirms ₹300 Cr FY'27 EBITDA as a floor, backs it with Q1 delivery, operating leverage and a bottom-up plan, but deliberately avoids overselling by using measured language (‘comfortably cross’, ‘floor’, ‘hopeful’ for Rule of 50).
• M&A discipline towards larger, non-distressed assets: Acquisition strategy has pivoted from distressed turnarounds to profitable assets with inherent strengths in education and science, financed through cash and debt without equity dilution, focusing on cultural fit and AI-tailwind domains.

Operational commentary

• AI-driven productivity gains in Research Solutions: DigiCore, Research Integrity Check and AI-enabled composition deployed at scale, one-touch workflows reducing costs and lifting segment EBITDA margin to 45.1%.
• Unbound Medicine closed its first full quarter within MPS, adding 841 institutional clients (up from 404 a year ago), a high-renewal subscription base and cross-sell potential with Liberate's corporate learning solutions.
• Corporate Learning segment turned a corner: EBITDA grew 60.7% on 6.9% revenue growth, margin expanded from 16.9% to 25.3% after headcount reduction and shift to a gig/associate delivery model.
• Education segment revenue surged 42.2% YoY to ₹73.41 Cr, driven by Unbound and organic expansion in AI-enabled content, accessibility, and AI-instructional-quality review work with large US K-12 and higher-ed clients.
• Company-wide shift from effort-based to outcomes-based pricing gaining traction across research (author acceptance, peer review), education (subscriptions) and corporate learning (performance enablement).
• AJE author solutions reset completed; launched Pre-Submission Peer Review with demand running ahead of plan; AJE now set to grow on value, not volume.
• Education accessibility line building toward a large journals rollout later in FY'27.
• Platform stack (HighWire, DigiCore Pro, THINK365) secured multi-year, mission-critical contracts with top publishers, increasing revenue stickiness.

Analyst Q&A

• Q. What is driving management exits and how are you ensuring operational continuity and cultural alignment across geographies?

  Rahul Arora explained that talent machine is expanding; mistakes are sometimes made but success rate is above market; core EEE values (excellence, efficiency, empathy) and ownership mindset are the cultural glue. Internal promotions have increased, and acquisitions are integrated through these values.

• Q. Client count fell from 906 to 841 QoQ – is there account pruning?

  Rahul Arora stated the only pruning in the business is AJE's consumer base, which Christine described; no other rationalisation.

• Q. Given AI capabilities, why can't organic growth be much higher than the early teens?

  Rahul Arora accepted the challenge: MPS is not settling; target is to outperform market growth rates in all segments. Acknowledged Corporate Learning underperformed at 6.9% and needs to catch up; aspiration is late-teens organic growth.

View source

Research and educational content only. Not investment advice.